Clinical Trials · NCT00002779
Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Alliance for Clinical Trials in Oncology
- Enrollment
- 34
- Start date
- Feb 1998
- Locations
- 20 sites, United States, Canada
- Primary endpoint
- response rate